PHILIDELPHIA, PA / ACCESSWIRE / November 14, 2020 / Kaskela Law LLC announces that it is investigating Emisphere Technologies, Inc. ("Emisphere") (OTC PINK: EMIS) on behalf of the company's stockholders.
On November 6, 2020, Emisphere announced that it had entered into an agreement to be acquired by Novo Nordisk A/S at a price of $7.82 per share in cash. Following the closing of the proposed acquisition, shares of Emisphere's stock will no longer be publicly traded.
The investigation seeks to determine whether the agreed-to $7.82 per share represents adequate consideration for Emisphere's shares, and whether Emisphere's officers and/or directors violated the securities laws or breached their fiduciary duties in agreeing to sell the company to Novo Nordisk.
Emisphere stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585, or by email at [email protected] or online at http://kaskelalaw.com/case/emisphere-technologies-inc/, to receive additional information about this investigation and their legal rights and options.
Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740
www.kaskelalaw.com
[email protected]
This notice may constitute attorney advertising in certain jurisdictions.
SOURCE: Kaskela Law LLC